Clinics in Dermatology
Volume 27, Issue 6 , Pages 537-544 , November 2009

Melanoma in the elderly patient: relevance of the aging immune system

  • Upendra P. Hegde, MD

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, The Carole and Ray Neag Comprehensive Cancer Institute, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Nitya Chakraborty, PhD

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, The Carole and Ray Neag Comprehensive Cancer Institute, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
    • ,
  • Philip Kerr, MD

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, The Carole and Ray Neag Comprehensive Cancer Institute, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
    • ,
  • Jane M. Grant-Kels, MD

      Affiliations

    • Department of Dermatology, MC 6230, The Carole and Ray Neag Comprehensive Cancer Institute, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics. CA Cancer J Clin. 2008;58:71–96
  2. Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–3648
  3. Marks R, Jolley D, McCormack C, Dorevitch AP. Who removes pigmented skin lesions?. J Am Acad Dermatol. 1997;36:721–726
  4. Balch CM, Soong S-J, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on cancer melanoma staging system. J Clin Oncol. 2001;19:3622–3634
  5. Chang CK, Jacobs IA, Vizgirda VM, Salti G. Melanoma in the elderly patient. Arch Surg. 2003;138:1135–1138
  6. Chao C, Martin CGR, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann of Surg Oncol. 2003;11:259–264
  7. Chagpar RB, Ross MI, Reintgen DS, et al. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res. 2007;143:164–168
  8. Murasko DM, Bernstein ED, Gardner EM, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol. 2002;37:427–439
  9. Christenson B, Pauksen K, Sylvan PE. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J. 2008;5:1–9
  10. Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006;42:1093–1101
  11. Atzpodien J, Wandert T, Reitz M. Age does not impair the efficacy of immunotherapy in patients with metastatic renal cell carcinoma. Crit Rev Oncol Hematol. 2005;55:193–199
  12. Quan W, Ramirez M, Taylor C, et al. Administration of high–dose continuous infusion interleukin-2 to patients age 70 or over. Cancer Biother Radiopharm. 2005;20:11–15
  13. Tagawa ST, Cheung E, Banta W, et al. Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with stage IV melanoma. Cancer. 2006;106:1353–1357
  14. Ribas A, Camacho LH, Lopez-Berestein G, et al. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. J Clin Oncol. 2005;23:8968–8977
  15. Marshall J, Forester TH, Purdie DM, et al. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma. Immunol Cell Biol. 2006;84:295–302
  16. Provinciali M, Smorlesi A, Donnini A, et al. Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine. 2003;21:843–848
  17. Boon T, Coulie PG, Van den Eynde BJ, et al. Human T cell responses against melanoma. Ann Rev Immunol. 2006;24:1–34
  18. Mukherji B, Chakraborty NG, Yamasaki S, et al. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc Natl Acad Sci. 1995;92:8078–8082
  19. Chakraborty NG, Li L, Sporn JR, et al. Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell- based tumor vaccines. J Immunol. 1999;162:5576–5583
  20. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr Opin Immunol. 2004;16:151–156
  21. Aspinall R. Age-related changes in the function of T cells. Microsc Res Tech. 2003;62:508–513
  22. Gupta S. Tumor necrosis factor-α-induced apoptosis in T cells from aged humans: a role of TNFR-1 and downstream signaling molecules. Exp Gerontol. 2002;37:293–299
  23. Han S, Yang K, Ozen Z, et al. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol. 2003;170:1267–1273
  24. Grolleau-Julius A, Garg MR, Mo R, et al. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8α- dendritic cell function. J Gerontol A Biol Sci Med Sci. 2006;61A:1039–1047
  25. Pawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J Leukoc Biol. 1998;64:703–712
  26. Salminen A, Huuskonen J, Ojala J, et al. Activation of innate immunity system during aging: NF-KB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev. 2008;7:83–105
  27. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–270
  28. Leng S, Chaves P, Koenig K, et al. Serum Interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002;50:1268–1271
  29. Leng SX, Xue Q-L, Tian J, et al. Inflammation and frailty in older women. J Am Geriatr Soc. 2007;55:864–871
  30. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982;156:1577–1586
  31. Nishioka T, Shimizu J, Iida R, et al. CD4+ CD25+ Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol. 2006;176:6586–6593
  32. Tsaknaridis L, Spencer L, Culbertson N, et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res. 2003;74:296–308
  33. Gregg R, Smith CM, Clark FJ, et al. The number of human peripheral blood CD4+CD25high regulatory T cells increases with age. Clin Exp Immunol. 2005;140:1365–2249
  34. Hegde UP, Chhabra A, Chakraborty NG. Lack of T reg cell function and melanoma tumor antigen-specific responses in some elderly patients. In: Proceedings of 99th Annual Meeting of American Association of Cancer Research, Abstract 248, San Diego, CA, April 12-16. 2008;

PII: S0738-081X(08)00189-2

doi: 10.1016/j.clindermatol.2008.09.012

Clinics in Dermatology
Volume 27, Issue 6 , Pages 537-544 , November 2009

Article Tools

* Image Usage & Resolution